Skip to content

Insider · CIK 0001223697

Don M Bailey

director

Files at LCTX (Lineage Cell Therapeutics, Inc.). First filing Feb 8, 2024, latest Feb 8, 2024.

In brief

Don M Bailey files SEC Form 4 as director at LCTX (Lineage Cell Therapeutics, Inc.). Since Feb 8, 2024, Don M Bailey has reported 1 open-market buy worth $100k and 0 open-market sells worth $0, the latest filed on Feb 8, 2024.

A track record needs three past buys with six months of prices behind them; Don M Bailey has 0, so none is measured yet.

The newest scored trade: bought $100k of LCTX on Feb 8, 2024, filed Feb 8, 2024, scored 47 (moderate).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$100k bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

LCTX: Lineage Cell Therapeutics, Inc.

LCTXOct 12, 2026 · close 0.95

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
47Moderate
LCTXbuy 2
Lineage Cell Therapeutics, Inc.
$100k
96,155 shares
+153%+26% from low-29% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Sep 24, 2025 LCTX
LINEAGE CELL THERAPEUTICS, INC.
60,000
0.03% of outstanding
$96kSep 24, 2025$97k
Sep 10, 2025 LCTX
LINEAGE CELL THERAPEUTICS, INC.
80,000
0.03% of outstanding
$97kSep 10, 2025none

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jul 1, 2024LCTX
Lineage Cell Therapeutics, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+75,000$0.00$075,000Jul 3, 2024
Feb 8, 2024LCTX
Lineage Cell Therapeutics, Inc.
POpen-market purchase
Common Shares, no par valueindirect: By The Bailey Family Trust
+96,155$1.04$100k158,801Feb 8, 2024

Questions about Don M Bailey

Answered from the filings on this page, as of the latest one.

Is Don M Bailey buying or selling?

Not in the last 12 months. Don M Bailey's latest open-market trade on SEC Form 4 was bought $100k of LCTX on Feb 8, 2024.

How did Don M Bailey's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Don M Bailey has 0.

Where does Don M Bailey file Form 4?

Don M Bailey has filed Form 4 at LCTX (Lineage Cell Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Don M Bailey: insider trades and track record | InsiderTell